Chargement en cours...
HCV cure for everyone or which challenges remain?
Following the approval of the first HCV direct-acting antiviral (DAA) in 2011, an unforeseen revolution in the treatment of chronic hepatitis C has taken place. In 2015 several all-oral DAA regimens, combining agents from different families (NS5B nucleotide inhibitors, NS5B non-nucleoside inhibitors...
Enregistré dans:
| Publié dans: | J Virus Erad |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mediscript Ltd
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946681/ https://ncbi.nlm.nih.gov/pubmed/27482396 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|